Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran.

Mohammadali Davarpanah,Fatemeh Sari Aslani,Masumeh Rassaei

doi:10.1155/2015/563851

Mohammadali Davarpanah, Fatemeh Sari Aslani + Show 1 more

Open Access

https://doi.org/10.1155/2015/563851

Copy DOI

Abstract

Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where in the world HIV/VL coinfection has become endemic. The case here suffers from both AIDS and visceral-cutaneous leishmaniasis. We report an Iranian woman with disseminated cutaneous and visceral leishmaniasis who became positive for HIV test.

Highlights

Leishmaniasis is a vector-borne infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis
Visceral leishmaniasis presents with hepatosplenomegaly, fever, weight loss, and pancytopenia
Disseminated cutaneous leishmaniasis exists as a syndrome with 100 acne papules in immunocompetent patients in Brazil

Summary

Introduction

Leishmaniasis is a vector-borne infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. About 90% of cutaneous leishmaniasis occurs in Iran, Saudi Arabia, Syria, the Middle East, Afghanistan, and Brazil [1]. VL is endemic in nine European countries. The World Health Organization has estimated a total of VL incidences of approximately 410–620 cases each year during 2003 to 2008 in these European countries [2]. L. tropica and L. major, which are the causative agents of cutaneous leishmaniasis, have been reported in the Middle East. In southern European area, visceral leishmaniasis has become endemic among HIV infected patients [1]. Common clinical manifestations of VL such as fever, weight loss, and hepatosplenomegaly do not always occur among coinfected cases [5].

Case Report

Findings

Discussion